Genzyme touts positive results for MS drug Lemtrada - Boston Herald

[**Genzyme touts positive results for MS drug Lemtrada**](http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF5FFqM3lW3ufVEM4dbUsJ3VXWldA&url=http://www.bostonherald.com/business/technology/general/view/20221101genzyme_touts_positive_results_for_ms_drug_lemtrada/)
**Boston Herald**
"There is a tremendous unmet need for treatments that address the progression of **disability** that people living with multiple sclerosis can experience," said Genzyme CEO David Meeker. "Genzyme set a new standard by comparing Lemtrada exclusively to an **...**
[News briefs from Sanofi, Biogen/SOBI and Novartis](http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG0XfpdYDYaOooHrpOszJ7Kme3Z4Q&url=http://www.thepharmaletter.com/file/117696/news-briefs-from-sanofi-biogensobi-and-novartis.html)The Pharma Letter

[**all 22 news articles&nbsp_place_holder;»**](http://news.google.com/news/more?ncl=djeGSj8eq2cgBjMXsCA4hvBBU7ALM&ned=us)

URL: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF5FFqM3lW3ufVEM4dbUsJ3VXWldA&url=http://www.bostonherald.com/business/technology/general/view/20221101genzyme_touts_positive_results_for_ms_drug_lemtrada/